Substance-related exogenous psychosis: a postmodern syndrome
Giovanni Martinotti, Luisa de Risio, Chiara Vannini, Fabrizio Schifano, Mauro Pettorruso, Massimo Di Giannantonio
CNS Spectrums June 25, 2020 DOI: 10.1017/s1092852920001479 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Longitudinal Peer reviewed |
|---|---|
| Keywords | Psychosis Psychopathology Schizophrenia object-oriented programming Schizotypy Clinical psychology |
| Citations | 102 |
| Key points | Proposes that substance-related exogenous psychosis (SREP) is a distinct clinical entity, separate from schizophrenia, characterized by specific psychopathological features and covering both transient and persistent substance-induced psychoses. |
Abstract
There is growing recognition that substance use is associated with the emergence of psychosis.Elements of post-modernity dominate contemporary social contexts and operate as existential background factors that contribute to the emergence of substance-related psychotic phenomena, particularly use of potent and highly rewarding novel psychoactive substances (NPS). About 25% of first-episode psychoses are substance-induced (SIP). DSM-5 SIP diagnosis is based on the assumption that symptoms are transient and disappear after sustained abstinence. This narrowed definition does not consider the issue of persistent SIP. There is a clear need for a new diagnostic framework that provides reliable, unambiguous clinical criteria to differentiate between comorbid conditions (i.e., schizophrenia patients with a substance use disorder) and substance-related psychoses. In the present contribution, we aim to outline a novel and separate clinical entity: substancerelated exogenous psychosis (SREP). Within this diagnostic category, we refer to both transientand persistent psychoses associated with substance use. SREP is conceived as a distinct psychoticdisorder with psychopathological specificities that clearly differentiate it from schizophrenia. We address differences in terms of clinical presentation, epidemiology, etiological models and treatment response. SREP is characterized by altered states of consciousness, persecutory delusions, visual and cenesthetic hallucinations, impulsivity and psychomotor agitation, affectiveand negative symptoms, a pervasive feeling of unreality and intact insight. Delusions are typically secondary to abnormal perception resulting from a characteristic "sensorialization" of the world. Longitudinal studies are warranted to substantiate our hypothesis of a novel diagnostic categoryand support the clinical validity of SREP. This may have important implications in terms of early differential diagnosis and staging (i.e., between comorbid conditions, persistent and transientsubstance-related psychotic states) as well as choice of treatment interventions.
Citations in the library
Cited by 24
- Duration of Untreated Disorder and Cannabis Use: An Observational Study on a Cohort of Young Italian Patients Experiencing Psychotic Experiences and Dissociative Symptoms International Journal of Environmental Research and Public Health November 30, 2021
- Ibogaine/Noribogaine in the Treatment of Substance Use Disorders: ASystematic Review of the Current Literature Current Neuropharmacology October 20, 2022
- Club Drugs: Psychotropic Effects and Psychopathological Characteristics of a Sample of Inpatients Frontiers in Psychiatry August 31, 2020
- Third-Generation Antipsychotics and Lurasidone in the Treatment of Substance-Induced Psychoses: A Narrative Review. Healthcare January 29, 2024
- The Potential Role of Serotonergic Hallucinogens in Depression Treatment Life July 29, 2021
and 19 more in the library
Cites 14
- “Spiceophrenia”: a systematic overview of “Spice”‐related psychopathological issues and a case report Human Psychopharmacology: Clinical and Experimental July 1, 2013
- Legal highs: staying on top of the flood of novel psychoactive substances Therapeutic Advances in Psychopharmacology January 26, 2015
- New/emerging psychoactive substances and associated psychopathological consequences Psychological Medicine July 22, 2019
- New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic'). Journal of Psychopharmacology November 1, 2005
- Novel psychoactive substances: the pharmacology of stimulants and hallucinogens Expert Review of Clinical Pharmacology March 17, 2016
and 9 more in the library